Relfydess: A Game-Changer in Brotox -Longer Lasting, Faster Results for Men

Addressing the Longevity Challenge in Male Neuromodulator Treatments

As an aesthetic practice exclusively treating male patients, we frequently encounter a familiar frustration: the diminishing returns of traditional wrinkle treatments. For many men receiving 'Brotox' in Manchester, the effects of their toxin start to fade significantly, with muscle movement returning around the 8 to 12-week mark.

We know some of these poor responders can be linked to external factors- such as inexperienced practitioners using incorrect injection depth or misinterpreting male facial anatomy- or, worse, the use of unverified black-market products.

However, even with our own high-dose, anatomically-precise treatments, we've had patients (even our own Dr. Andy) barely get to the two-month mark of longevity. This ongoing challenge in maintaining that powerful, refreshed aesthetic for men is precisely why we were so excited to attend the recent launch of Relfydess here in Manchester.

Introducing Relfydess: A New Era of Toxin Technology

Relfydess (active molecule: relabotulinumtoxinA) is the latest next-generation toxin to be licensed in the UK, developed by Galderma after 15 years of rigorous research.

What makes Relfydess truly revolutionary is its unique formulation: the active molecule is presented in its highest-active form, free from complexing proteins and human or animal components. This "clean" formulation is designed to minimise the risk of antibody formation, which can lead to resistance and reduced efficacy over time.

The Clinical Edge: Speed and Sustained Power for the Modern Man

The clinical significance for our male patients is dual: a much faster onset and significantly longer lasting results.

Feature	Relfydess Clinical Data (Source: READY Trials)	Impact for Men in Manchester
Rapid Onset	Up to 39% of patients notice visible results within the first 24 hours.	Quick results are vital for busy professionals who need to look their best, fast.
Sustained Longevity	Up to 75% of patients still maintain a positive, meaningful effect at 6 months.	Double the duration of many traditional toxins, drastically reducing treatment frequency.

This six-month longevity is a significant advancement and positions Relfydess to completely change the "Brotox" landscape for Manchester men.

Our Practice Commitment and the Economic Advantage

While personal opinion is the weakest form of evidence (a principle Galderma supports with its four extensive clinical trials), Dr. Andy and I have been thoroughly impressed by the results in our initial male patients.

We firmly believe this new toxin will produce superior, more consistent results for our patients and presents a better economic value in the long run. Imagine: patients currently needing wrinkle reduction treatment four times a year could potentially drop their frequency to just twice a year, saving them both time and money.

A Responsible Choice

Furthermore, Galderma, the developer of Relfydess, has taken steps to reduce the carbon footprint in the production of this toxin, aligning with our commitment to responsible practice.